Aurigene Pharmaceutical Services Header Aurigene Pharmaceutical Services Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the pharmaceutical Marketplace for latest FDF dossiers enquiries of Apalutamide on PharmaCompass.com

    Client Email Product

    Apalutamide

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    26
    US DMFs Filed

    US DMFs Filed

    8
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    23
    API REF. PRICE (USD / KG)
    14,292

    API Market Place

    4
    INTERMEDIATES
    9
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    2
    Europe

    Europe

    0

    Canada

    Canada

    1
    Australia

    Australia

    1
    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    1
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,054.00

    Annual Reports

    0

    FDF Market Place

    4
    EXCIPIENTS
    91
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    26

    USFDA Exclusivities

    1
    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    47
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    left grey arrow
    right gray arrow
    Post an EnquiryPost an Enquiry
    Price InfoPrice Info
    Full View ScreenFull Screen View
    Bulgaria.png
    Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA17021]
    Specialized Hospital For Active Treatment Of Oncological Diseases Dr. Marko Antonov Markov-Varna Ltd. is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 12-May-2023. 1. Tramadol (50 mg) Capsules. The required quantity is 15,000 units. 2. Apalutamide (60 mg) Tablets. The required quantity is 36,000 units.
    03 May 2023

    Reply Comment (3)

    Reply text-arrow

    Bulgaria.png
    Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA16249]
    Complex Oncology Center-Veliko Tarnovo Ltd is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 24-Feb-2023. 1. Apalutamide (60 mg) Tablets. The required quantity is 864,000 units. 2. Fentanyl (133 mcg) Sublingual Tablets. The required quantity is 638,400 units. 3. Olaparib (150 mg) Tablets. The required quantity is 604,800 units.
    31 Jan 2023

    Reply Comment (5)

    Reply text-arrow

    Bulgaria.png
    Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA14476]
    Complex Oncology Center - Shumen Ltd is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 22-Aug-2022. 1. Apalutamide (60 mg) Film Coated Tablets. The required quantity is 17,280 units. 2. Encorafenib (75 mg) Capsules. The required quantity is 15,000 units.
    27 Jul 2022

    Reply Comment (1)

    Reply text-arrow

    Croatia.png
    Tender// Various Finished Dosage Formulations needed in Croatia [ENA09642]
    Clinical Hospital Center Zagreb is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 8-March-2021. 1. Paclitaxel (5 mg/ ml) Solution for Infusion. The required quantity is 300 units. 2. Rituximab (1x100 mg/ 10 ml and 1x 500 mg/ 50 ml) Concentrate Solution for Infusion. The required quantity is 6 units and 400 units respectively. 3. Trastuzumab (1x150 mg) Solution for Injection. The required quantity is 100 units. 4. Bevacizumab (25 mg/ ml) Concentrate Solution for Infusion. The required quantity is 5 units and 1,500 units. 5. Daratumumab (1x1800 mg/ 15 ml) Solution for injection. The required quantity is 1,000 units. 6. Apalutamide (112 x 60 mg) Tablets. The required quantity is 56,448 units. 7. Durvalumab (50 mg/ ml) Concentrate solution for infusion. The required quantity is 100 units and 960 units. 8. Siponimod (12 x 0.25 mg) Tablets. The required quantity is 600 units and 5,280 units. 9. Siponimod (28 x 2 mg) Tablets. The required quantity is 600 units and 14,168 units.
    03 Feb 2021

    Reply Comment (9)

    Reply text-arrow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    transo-pharm-handels-gmbh-m-2023-12-11

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Aarti Pharmalabs Apalutamide

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search